GSK Plc Form 6-K Summary
Business Context and Reporting Period
This Form 6-K filing by GSK Plc, dated July 1, 2025, serves as a notification to the market regarding the Company's total voting rights and capital structure. The report is filed in conformity with the Financial Conduct Authority's Disclosure Guidance and Transparency Rule 5.6.1R.
Key Financial Metrics
The filing does not provide financial performance data such as revenue, profit, cash flow, margins, debt, or liquidity. The document focuses exclusively on share capital and voting rights.
Material Changes and Capital Structure
As of June 30, 2025, the Company's issued share capital consisted of 4,315,370,199 Ordinary Shares of 31 1/2 pence each. Of these, 226,172,571 Ordinary Shares were held in Treasury. Consequently, the total number of voting rights in the Company is 4,089,197,628. This figure is designated for use by shareholders to determine notification requirements under FCA rules.
Guidance, Outlook, and Risks
The filing contains no management commentary, financial guidance, outlook, risk factors, contingencies, or unusual items. It is a statutory disclosure of share count.
Key Facts for Investor Verification
- Total issued Ordinary Shares as of June 30, 2025: 4,315,370,199.
- Ordinary Shares held in Treasury: 226,172,571.
- Total voting rights available: 4,089,197,628.
- Share price per Ordinary Share: 31 1/2 pence.
- Reporting date for capital structure: June 30, 2025.